FierceBiotech 2025-12-16 December deal flurry rolls on with Genentech-Caris cancer collab worth up to $1.1B
FierceBiotech 2025-12-16 Xoma acquires another struggling biotech, this time zeroing in on Generation Bio
FierceBiotech 2025-12-16 Aldeyra dry eye disease candidate hit by FDA delay amid shifting agency guidance, biotech says
FierceBiotech 2025-12-16 Ramaswamy-backed Ambros Therapeutics launches with $125M to develop pain drug
BioPharma Dive 2025-12-16 Nektar sees silver lining as autoimmune drug ‘narrowly’ misses in alopecia study
Endpoints News 2025-12-16 J&J backs financing round for Stanford CAR-T cell therapy spinout Link Cell
Endpoints News 2025-12-16 OrsoBio obesity data; Monte Rosa's prostate cancer pill; Development pacts for Adaptive and SandboxAQ